Stay updated on Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a Locations section listing North Carolina, Texas, and Virginia; updated the page revision to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-24T13:50:46.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.2.0 to v3.3.2, a minor maintenance change with no substantive study content altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T12:01:06.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Removed the banner about government funding lapse and operating status; no study data or links were changed.
    Difference
    0.4%
    Check dated 2025-11-18T07:16:51.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Arms B and C are closed to enrollment, and Arm A remains open for enrollment.
    Difference
    0.4%
    Check dated 2025-11-03T21:21:41.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T05:58:42.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to core content or functionality based on the provided additions/deletions.
    Difference
    0.1%
    Check dated 2025-09-29T03:15:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.